HT-3951

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameHT-3951
Drug Alias NameHT-3951
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoamine oxidase B inhibitors
TargetsMonoamine oxidase B
Therapy Area/IndicationsIschemic Stroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDart Neuroscience Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDart Neuroscience Llc
Active IndicationsN/A
Inactive IndicationsIschemic Stroke

Other Information

ATC CodeN/A
Related LinksN/A